See What HealthDay Can Do For You
Contact Us

Diabetes Education for PCPs Improves Disease Management

Patients from clinics with computer-based case study programs have better glucose control

THURSDAY, Aug. 5 (HealthDay News) -- Diabetes patients from clinics where primary care physicians (PCPs) participate in a program of computer-based diabetes case studies improve glucose control better than patients from clinics where PCPs do not undergo the learning intervention, according to a study in the August issue of Diabetes Care.

JoAnn M. Sperl-Hillen, M.D., of the HealthPartners Research Foundation in Minneapolis, and colleagues randomized 11 Minnesota clinics with 41 consenting PCPs to receive either an educational intervention consisting of 12 simulated type 2 diabetes cases designed to remedy specific physician deficits, or no intervention. The researchers compared the two groups' patients for changes in A1C, blood pressure, and low-density lipoprotein (LDL) cholesterol at 12 months, and also compared costs.

The investigators found that patients with baseline A1C of at least 7 percent from clinics that had the learning program had significantly improved glycemic control after the intervention (intervention effect, −0.19 percent mean A1C and +6.7 percent in A1C below 7 percent goal achievement). Among patients who had a baseline A1C of 7 percent or greater, 29.2 percent from the program clinics and 22.5 percent from the control clinics had an A1C less than 7 percent at follow-up. However, the control clinic patients reduced LDL from baseline to follow-up more than the patients from the program clinics (intervention effect, −5.1 mg/dL). Costs totaled $71 less for each patient from the program clinics than from the control clinics (P = 0.63).

"A brief individualized case-based simulated learning intervention for PCPs led to modest but significant glucose control improvement in adults with type 2 diabetes without increasing costs," the authors write.

One study author has received support indirectly for multi-site drug trials from pharmaceutical companies, while another author owns pharmaceutical company stock.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.